Home › Mantle Cell Lymphoma › Maryland › Baltimore
Mantle Cell Lymphoma clinical trials in Baltimore, MD
5 studies for Mantle Cell Lymphoma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecruitingPhase 3
- The University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
RecruitingPhase 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi away
Mantle Cell Lymphoma trials in other cities
- Baldwin Park, CA15 studies
- Houston, TX15 studies
- Durham, NC13 studies
- Seattle, WA12 studies
- Milwaukee, WI12 studies
- New York City, NY12 studies
- Boston, MA11 studies
- Columbus, OH11 studies
- Nashville, TN11 studies
- Chicago, IL10 studies
- Portland, OR9 studies
- Rochester, MN9 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.